1. Market Research
  2. > Pharmaceutical
  3. > Drug Discovery and Development Market Trends
  4. > Agoraphobia Global Clinical Trials Review, H1, 2014

Agoraphobia Global Clinical Trials Review, H1, 2014

  • May 2014
  • -
  • Global Data
  • -
  • 65 pages

Agoraphobia Global Clinical Trials Review, H1, 2014

Summary

GlobalData's clinical trial report, “Agoraphobia Global Clinical Trials Review, H1, 2014" provides data on the Agoraphobia clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Agoraphobia. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Agoraphobia. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table Of Contents

Agoraphobia Global Clinical Trials Review, H1, 2014
Table of Contents
Table of Contents2
List of Tables 3
List of Figures 4
Introduction 5
Agoraphobia 5
Report Guidance 5
Clinical Trials by Region 6
Clinical Trials and Average Enrollment by Country 7
Top Countries Contributing to Clinical Trials in Asia-Pacific 9
Top Countries Contributing to Clinical Trials in Europe 10
Top Countries Contributing to Clinical Trials in North America 11
Top Countries Contributing to Clinical Trials in Central and South America 12
Clinical Trials by G7 Countries: Proportion of Agoraphobia to Central Nervous System Clinical Trials 13
Clinical Trials by Phase in G7 Countries 14
Clinical Trials in G7 Countries by Trial Status 15
Clinical Trials by E7 Countries: Proportion of Agoraphobia to Central Nervous System Clinical Trials 16
Clinical Trials by Phase 17
In Progress Trials by Phase 18
Clinical Trials by Trial Status 19
Clinical Trials by End Point Status 20
Subjects Recruited Over a Period of Time 21
Clinical Trials by Sponsor Type 22
Prominent Sponsors 23
Top Companies Participating in Agoraphobia Therapeutics Clinical Trials 24
Prominent Drugs 25
Clinical Trial Profiles 26
Clinical Trial Overview of Top Companies 26
Bluefish Pharmaceuticals AB 26
Clinical Trial Overview of Bluefish Pharmaceuticals AB 26
Pfizer Inc. 27
Clinical Trial Overview of Pfizer Inc. 27
Forest Laboratories, Inc. 28
Clinical Trial Overview of Forest Laboratories, Inc. 28
Clinical Trial Overview of Top Institutes / Government 29
Charite - Universitatsmedizin Berlin 29
Clinical Trial Overview of Charite - Universitatsmedizin Berlin 29
Federal University of Rio de Janeiro 30
Clinical Trial Overview of Federal University of Rio de Janeiro 30
Sorlandet Hospital HF 31
Clinical Trial Overview of Sorlandet Hospital HF 31
Ministry of Education and Research, Germany 32
Clinical Trial Overview of Ministry of Education and Research, Germany 32
St. Elisabeth Hospital 33
Clinical Trial Overview of St. Elisabeth Hospital 33
National Institute of Mental Health 34
Clinical Trial Overview of National Institute of Mental Health 34
New York State Psychiatric Institute 35
Clinical Trial Overview of New York State Psychiatric Institute 35
VU University Medical Center 36
Clinical Trial Overview of VU University Medical Center 36
Hamilton Health Sciences 37
Clinical Trial Overview of Hamilton Health Sciences 37
Hospices Civils de Lyon 38
Clinical Trial Overview of Hospices Civils de Lyon 38
Five Key Clinical Profiles 39
Appendix 63
Abbreviations 63
Definitions 63
Research Methodology 64
Secondary Research 64
About GlobalData 65
Contact Us 65
Disclaimer 65
Source 65

List of Tables
Agoraphobia Therapeutics, Global, Clinical Trials by Region, 2014* 6
Agoraphobia Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 7
Agoraphobia Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 8
Agoraphobia Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2014* 9
Agoraphobia Therapeutics Clinical Trials, Europe, Top Countries, 2014* 10
Agoraphobia Therapeutics Clinical Trials, North America, Top Countries, 2014* 11
Agoraphobia Therapeutics Clinical Trials, Central and South America, Top Countries, 2014* 12
Proportion of Agoraphobia to Central Nervous System Clinical Trials, G7 Countries (%), 2014* 13
Agoraphobia Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 14
Agoraphobia Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 15
Proportion of Agoraphobia to Central Nervous System Clinical Trials, E7 Countries (%), 2014* 16
Agoraphobia Therapeutics, Global, Clinical Trials by Phase, 2014* 17
Agoraphobia Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 18
Agoraphobia Therapeutics, Global, Clinical Trials by Trial Status, 2014* 19
Agoraphobia Therapeutics Clinical Trials, Global, by End Point Status, 2014* 20
Agoraphobia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 21
Agoraphobia Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 22
Agoraphobia Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 23
Agoraphobia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 24
Agoraphobia Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 25
Agoraphobia Therapeutics Clinical Trials Market, Global, Clinical Trials by Bluefish Pharmaceuticals AB, 2014* 26
Agoraphobia Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2014* 27
Agoraphobia Therapeutics Clinical Trials Market, Global, Clinical Trials by Forest Laboratories, Inc., 2014* 28
Agoraphobia Therapeutics Clinical Trials Market, Global, Clinical Trials by Charite - Universitatsmedizin Berlin, 2014* 29
Agoraphobia Therapeutics Clinical Trials Market, Global, Clinical Trials by Federal University of Rio de Janeiro, 2014* 30
Agoraphobia Therapeutics Clinical Trials Market, Global, Clinical Trials by Sorlandet Hospital HF, 2014* 31
Agoraphobia Therapeutics Clinical Trials Market, Global, Clinical Trials by Ministry of Education and Research, Germany, 2014* 32
Agoraphobia Therapeutics Clinical Trials Market, Global, Clinical Trials by St. Elisabeth Hospital, 2014* 33
Agoraphobia Therapeutics Clinical Trials Market, Global, Clinical Trials by National Institute of Mental Health, 2014* 34
Agoraphobia Therapeutics Clinical Trials Market, Global, Clinical Trials by New York State Psychiatric Institute, 2014* 35
Agoraphobia Therapeutics Clinical Trials Market, Global, Clinical Trials by VU University Medical Center, 2014* 36
Agoraphobia Therapeutics Clinical Trials Market, Global, Clinical Trials by Hamilton Health Sciences, 2014* 37
Agoraphobia Therapeutics Clinical Trials Market, Global, Clinical Trials by Hospices Civils de Lyon, 2014* 38

List of Figures
Agoraphobia Therapeutics, Global, Clinical Trials by Region (%), 2014* 6
Agoraphobia Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 7
Agoraphobia Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 8
Agoraphobia Therapeutics Clinical Trials, Europe, Top Countries (%), 2014* 10
Agoraphobia Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 11
Proportion of Agoraphobia to Central Nervous System Clinical Trials, G7 Countries (%), 2014* 13
Agoraphobia Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 14
Agoraphobia Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 15
Proportion of Agoraphobia to Central Nervous System Clinical Trials, E7 Countries (%), 2014* 16
Agoraphobia Therapeutics, Global, Clinical Trials by Phase (%), 2014* 17
Agoraphobia Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 18
Agoraphobia Therapeutics, Global, Clinical Trials by Trial Status, 2014* 19
Agoraphobia Therapeutics Clinical Trials, Global, by End Point Status, 2014* 20
Agoraphobia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 21
Agoraphobia Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 22
Agoraphobia Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 23
Agoraphobia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 24
Agoraphobia Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 25
GlobalData Methodology 64

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

The global CRO services market is estimated to grow at a CAGR of 7.4% from 2016 to 2021, to reach USD 41.86 billion by 2021 from USD 29.29 billion in 2016. Growth in this market is primarily attributed ...

Clinical Trial Imaging Market by Product & Services, Modality, End User - Global Forecast to 2021

Clinical Trial Imaging Market by Product & Services, Modality, End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • December 2016
  • by MarketsandMarkets

The global clinical trial imaging market is projected to reach USD 1069.7 million by 2021 from USD 773.4 million in 2016, at a CAGR of 6.7% from 2016 to 2021. Increase in R&D spending and growth in the ...

Pharmacovigilance Market: By Clinical Trial Phases (Preclinical Studies, Phase I/1, Phase II/2, Phase III/3, Phase IV/4 Trial); By Type of Service Providers (In House, Contract Outsourcing) & By Region-Forecast (2016-2022)

Pharmacovigilance Market: By Clinical Trial Phases (Preclinical Studies, Phase I/1, Phase II/2, Phase III/3, Phase IV/4 Trial); By Type of Service Providers (In House, Contract Outsourcing) & By Region-Forecast (2016-2022)

  • $ 5274
  • Industry report
  • September 2016
  • by Industry ARC

Pharmacovigilance is referred to as a practice of monitoring the effects of medical drugs after they have been licensed for use, especially in order to identify and evaluate previously unreported adverse ...

Global Clinical Trials Market

December 2016 $ 4250

ref:plp2014

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.